• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Frost & Sullivan names Seven Bridges product leader in genomics informatics

Frost & Sullivan names Seven Bridges product leader in genomics informatics

June 16, 2017
CenterWatch Staff

Seven Bridges, a provider of biomedical data analysis, received the Frost & Sullivan Product Leadership Award for the Genomics Informatics Industry.

The award recognizes Seven Bridges’ success in enabling pharmaceutical research and development, in addition to national genomics projects, and establishes the company as the market leader in this fast-growing industry.

“Frost & Sullivan firmly believes Seven Bridges offers a suite of biomedical data analysis tools, along with the scientific team, that make it the go-to provider of genomics informatics solutions for large pharmaceutical companies and national scientific projects,” said Christi Bird Ulan, senior research analyst, at Frost & Sullivan. “For its commitment to reducing bottlenecks and challenges in the genomics industry through its easy-to-use yet high-capability platform, Seven Bridges is the ideal recipient of the Frost & Sullivan Product Leadership Award in the genomics informatics industry.”

Seven Bridges builds software to analyze multi-omics and clinical data, accelerating research and improving health outcomes. It combines deep expertise in scientific computation and bioinformatics to support the world’s largest biomedical research projects across industry and government, including the U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. Seven Bridges has been recognized by various publications for its leading role in biomedical data analysis, including three Bio-IT World Best of Show awards—most recently in 2017—and the MIT Technology Review’s 50 Smartest Companies award.

“Seven Bridges is the pioneer developing technologies to help researchers integrate petabyte-scale biomedical data into all stages of their work, which leads to new discoveries and improved health,” said Brandi Davis-Dusenbery, CEO of Seven Bridges. “We are honored to receive this award from Frost & Sullivan; it validates the work of our team and clients.”

The Frost & Sullivan Product Leadership Award recognizes companies that provide consistently high standards of product or service quality or innovation. To determine the award recipient, analysts independently evaluate companies across two key factors divided into 10 benchmarking criteria. Seven Bridges received top ratings for both product attributes and business impact, with a clear lead over its competitors in both categories.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing